The Road Ahead for Social Security–A Summation of the Situation
The long-term dilemma faced by the Social Security and Medicare Trust Funds is not a self-correcting situation, and most Americans
Read More
Waste from pharmaceutical plants in India and China promotes antibiotic-resistant superbugs
(By Henry A. Waxman and Bill Corr for STAT) Superbugs, disease-causing microbes that have mutated to become resistant to antibiotics,
Read MoreThe insulin market is heading for a shakeup. But patients may not benefit
(By Rebecca Robbins for STAT) The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of
Read MoreWhy Is The News About TB So Bad?
(By Rina Shalkh-Lasko for NPR) Many countries think of TB as a disease of the past and this lack of
Read MoreOfficials Warn Some Older Marketplace Customers To Switch To Medicare
(By Susan Jaffe for Kaiser Health News) Ever since the Affordable Care Act’s health insurance marketplaces opened for business in
Read MoreThe ‘Swiss Agent’: Long-forgotten research unearths new mystery about Lyme disease
(By Charles Piller for STAT) The tick hunter was hopeful he had found the cause of the disabling illness, recently
Read MoreOpen Enrollment–Time to Re-Check Your Drug Coverage
The annual Medicare Open Enrollment period, which runs through December 7, provides an opportunity to re-examine your Part D drug
Read MoreOpen Enrollment–Some Specific Potential Cost-Savers to Look At
Medicare expert Philip Moeller, in a post today on philly.com, provides a synopsis of several key areas where Medicare participants
Read MoreMedicare Advantage Examined as Open Enrollment Kicks Off
Todd Campbell of Motley Fool takes a look at the changes in store for Medicare Advantage participants in 2017 in
Read MoreDoctors’ Pay to beSubjected to Quality Measures, Says Medicare
With procedural changes designed “to reward quality, penalize poor performance and avoid paying piecemeal for services,” the Medicare Access and CHIP
Read More